-
Plenary II Showcases Additional Compelling Scientific Abstracts
In Monday’s plenary session, investigators, including Walter P. Maksymowych, MD, FRCPC, MRCP, FACP, presented new data on gout flares and cardiovascular events, molecular heterogeneity in preclinical lupus, giant cell arteritis disease trajectory, obinutuzumab use in lupus, how methotrexate is metabolized, and what makes an MRI indicative of axial spondyloarthritis.
More news from #ACR26
-
Inaugural LRA Lupus Insight Prize Lectureship at ACR Convergence to Honor Landmark TLR7 Research
The prize recognizes seminal discoveries that shift the understanding of lupus. Greg Barton, PhD, and Olivia Majer, PhD, will discuss their research into how regulation of innate immune-sensing pathways governs susceptibility to lupus.
-
Upcoming Consensus Statement Will Help Inform Care for Patients with Rheumatoid Arthritis and Cardiovascular Disease
Multiple committee members who drafted the Consensus Statement on Managing Atherosclerotic Cardiovascular Disease and Rheumatoid Arthritis will review the report, including Daniel H. Solomon, MD, MPH.
ACR Convergence Newsmakers
-

Dermatology, Pulmonary Experts to Come Together to Share Secrets and Pearls About Systemic Sclerosis
Scott Matson, MD, will review management of interstitial lung disease, focusing on monitoring disease progression and therapeutic options when the disease does progress, and Erin Theisen, MD, PhD, will discuss adjunctive treatments that are common for dermatologists but less common for rheumatologists.
-

Session Contemplates Role of Aging in Diseases
Melanie Koenigshoff, MD, PhD, was one of a pair of speakers who explored the impact of aging on rheumatic diseases and avenues being explored to reverse its effects.
Presenter Spotlights






